Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects. [PDF]
Yilmaz Nas O +7 more
europepmc +1 more source
Quality of life after diet liberalization in individuals with phenylketonuria treated with Pegvaliase. [PDF]
Cazzorla C +8 more
europepmc +1 more source
Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review. [PDF]
Jones H, Strehle EM.
europepmc +1 more source
Improving sapropterin administration efficacy in PKU: Clinical practice case studies. [PDF]
Tosi M +7 more
europepmc +1 more source
Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study. [PDF]
Antoni G +4 more
europepmc +1 more source
Sapropterin Dihydrochloride Responsiveness in Phenylketonuria: A Case Series Exploring Gaps in Comprehensive Patient Monitoring. [PDF]
Lo Bianco M +12 more
europepmc +1 more source
Clinical assessment of growth patterns, weight, and dietary management in children and adults with phenylketonuria - a retrospective study. [PDF]
Bahtiri L +7 more
europepmc +1 more source
A Single-Center Genotype-Phenotype Correlation Cohort Study of Hyperphenylalaninemia Patients: Genetic Analysis as a Deterministic Tool for Treatment Consistency. [PDF]
Peker A +6 more
europepmc +1 more source
Phenylalanine homeostasis in metabolic disorders: epidemiological trends, pathophysiological mechanisms, and clinical treatment. [PDF]
Chen Y +7 more
europepmc +1 more source
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuria. [PDF]
Chandani HK +4 more
europepmc +1 more source

